艾米克斯生物制药 IMMX
$8.06 +$0.86 (+11.94%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $7.99 -0.87%
开盘$7.24
昨收$7.20
当日区间$7.16 – $8.17
成交量1.44M
市值$669.62M
市盈率（TTM）–
股息率–
IMMX 相关新闻
匹配 Immix Biopharma 或代码 IMMX 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for Immix Biopharma(IMMX.US), With a Forecast Between $24 to $30
- Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $26 正面
- LifeSci Capital Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $26
- LifeSci Capital Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $26 正面
- BofA Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating
- Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $15
- Morgan Stanley Maintains Immix Biopharma(IMMX.US) With Buy Rating, Cuts Target Price to $19 负面
- H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $25 正面
- Needham Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $21
- Needham Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $21
- BofA Securities Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $27
- LifeSci Capital Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $19
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX)
- H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $20 正面
- Citizens JMP Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $23
暂无评论——快来第一个聊聊 IMMX。
登录后参与讨论。